What is the utility of the urine pneumococcal antigen test (Binax NOW) in pediatric patients, particularly those under 2 years of age or with underlying health conditions, in diagnosing pneumococcal infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Urine Pneumococcal Antigen Test (Binax NOW) in Children

Primary Recommendation

Urinary antigen detection tests are NOT recommended for the diagnosis of pneumococcal pneumonia in children due to frequent false-positive results. 1

This is a strong recommendation based on high-quality evidence from the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. 1


Rationale for Non-Use

High False-Positive Rate in Children

  • The primary problem is nasopharyngeal colonization: Children who are asymptomatic carriers of S. pneumoniae in their nasopharynx frequently test positive on urinary antigen testing, making the test unreliable for distinguishing true infection from colonization. 2, 3

  • Specificity is unacceptably low: Studies demonstrate specificity ranging from only 55.9% to 81% in children with suspected pneumococcal infection, meaning up to 44% of children without pneumococcal disease will test positive. 4, 5, 6

  • False positives occur in 15-20% of febrile children without pneumococcal infection, and in approximately 10.7% of asymptomatic nasopharyngeal carriers. 4, 5

Age-Specific Concerns

  • Children under 2 years are particularly problematic: This age group has the highest rates of nasopharyngeal pneumococcal colonization (often 20-40% in daycare settings), making false-positive results even more common. 4, 5

  • The test cannot differentiate between colonization and invasive disease in young children, rendering it clinically unhelpful for management decisions. 2, 7


Limited Clinical Scenarios Where Test Performance is Better

Proven Invasive Disease (Not Diagnostically Useful)

  • Sensitivity is excellent (88-100%) in confirmed bacteremic pneumococcal disease, but this is a retrospective finding that doesn't help with initial diagnosis. 4, 8

  • In children with lobar pneumonia, sensitivity is 76%, but the poor specificity still limits clinical utility. 4

Pleural Fluid and CSF Testing (Different Application)

  • When applied directly to pleural fluid or CSF (not urine), the Binax NOW test shows better performance with 88% sensitivity and 72.5% specificity compared to PCR. 8

  • However, this is a different application than urinary testing and requires invasive sampling. 8


Alternative Diagnostic Approaches

Recommended Testing in Children with Suspected Pneumococcal Pneumonia

  • Blood cultures should be obtained in hospitalized children with moderate-to-severe pneumonia before initiating antibiotics, though yield is low (2-7%). 1

  • Rapid influenza testing is strongly recommended in all children with community-acquired pneumonia, as a positive test can eliminate the need for antibiotics if no bacterial coinfection is present. 1, 2

  • Chest radiography should be performed in children with hypoxemia, significant respiratory distress, or failed initial therapy. 1

What NOT to Use

  • Acute-phase reactants (CRP, ESR, procalcitonin) cannot be used alone to distinguish viral from bacterial pneumonia. 1

  • Urinary pneumococcal antigen tests are not recommended due to frequent false positives. 1, 2, 3


Common Pitfalls to Avoid

  • Do not order urinary pneumococcal antigen testing in children regardless of age or clinical severity—the false-positive rate makes it unreliable for clinical decision-making. 1

  • Do not use a positive urinary antigen test to justify antibiotic therapy in a child with viral symptoms, as colonization is common. 2, 5

  • Do not assume a negative test rules out pneumococcal disease in severely ill children—while sensitivity is high in bacteremia, it is only 36.4% in CSF and 50% in pleural fluid when testing urine. 6

  • Avoid testing in children with recent pneumococcal vaccination or known nasopharyngeal colonization, as this further increases false-positive rates. 7, 5


Clinical Decision Algorithm

For Suspected Pneumococcal Pneumonia in Children:

  1. Assess severity using clinical criteria (respiratory distress, hypoxemia, systemic signs). 1

  2. Obtain rapid influenza testing in all cases to guide antibiotic necessity. 1, 2

  3. If hospitalization required: Obtain blood cultures and chest radiography; do NOT obtain urinary pneumococcal antigen. 1

  4. If pleural effusion or empyema suspected: Consider direct testing of pleural fluid (culture, PCR, or Binax NOW on fluid itself—not urine). 8

  5. Initiate empiric antibiotic therapy based on clinical presentation and local resistance patterns, not on urinary antigen results. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Management of Pneumonia vs Influenza in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Testing for Mycoplasma pneumoniae in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnostic detection of Streptococcus pneumoniae PpmA in urine.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.